Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.580
-0.070 (-4.24%)
At close: Mar 28, 2025, 4:00 PM
1.630
+0.050 (3.16%)
After-hours: Mar 28, 2025, 7:07 PM EST

Armata Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Revenue
5.174.535.514.470.82
Upgrade
Revenue Growth (YoY)
14.24%-17.77%23.11%443.62%-
Upgrade
Cost of Revenue
34.4333.7735.0220.0214.44
Upgrade
Gross Profit
-29.25-29.24-29.51-15.54-13.62
Upgrade
Selling, General & Admin
13.1811.657.448.287.97
Upgrade
Operating Expenses
13.1811.657.448.287.97
Upgrade
Operating Income
-42.44-40.89-36.95-23.82-21.59
Upgrade
Interest Expense
-10.74-2.63--0.06-0.63
Upgrade
Interest & Investment Income
0.70.180.030.010.03
Upgrade
Other Non Operating Income (Expenses)
----0.01
Upgrade
EBT Excluding Unusual Items
-52.48-43.34-36.92-23.88-22.18
Upgrade
Other Unusual Items
33.57-25.71-0.73-
Upgrade
Pretax Income
-18.92-69.05-36.92-23.16-22.18
Upgrade
Net Income
-18.92-69.05-36.92-23.16-22.18
Upgrade
Net Income to Common
-18.92-69.05-36.92-23.16-22.18
Upgrade
Shares Outstanding (Basic)
3636342416
Upgrade
Shares Outstanding (Diluted)
5936342416
Upgrade
Shares Change (YoY)
63.71%5.20%42.27%46.84%104.93%
Upgrade
EPS (Basic)
-0.52-1.91-1.08-0.96-1.35
Upgrade
EPS (Diluted)
-0.89-1.91-1.08-0.96-1.35
Upgrade
Free Cash Flow
-39.43-55.57-34.69-24.88-19.09
Upgrade
Free Cash Flow Per Share
-0.67-1.54-1.01-1.03-1.16
Upgrade
Operating Margin
-820.18%-902.85%-670.77%-532.45%-2622.97%
Upgrade
Profit Margin
-365.60%-1524.51%-670.24%-517.55%-2695.14%
Upgrade
Free Cash Flow Margin
-762.08%-1226.91%-629.85%-556.08%-2320.05%
Upgrade
EBITDA
-41.11-39.92-36.05-22.65-20.47
Upgrade
D&A For EBITDA
1.330.970.891.171.11
Upgrade
EBIT
-42.44-40.89-36.95-23.82-21.59
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q